Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
Silence Therapeutics (SLN)
Share Price: 208.00p Change Today: -6.88p  Market Cap: 108.16m

SLN Overview

Silence Therapeutics is in the pharmaceuticals & biotechnology sector and is currently trading at 208.00p per share. In the last year Silence Therapeutics's share price has ranged from 190.00p to 375.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

6 Month Chart

SLN Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-09 1.72 (7.51) (246.59)p n/a n/a n/a n/a 0.0%
31-Dec-10 2.37 (8.80) (140.40)p n/a n/a n/a n/a 0.0%
31-Dec-11 0.69 (5.74) (56.17)p n/a n/a n/a n/a 0.0%
31-Dec-12 0.16 (26.28) (6,750.00)p n/a n/a n/a n/a 0.0%
31-Dec-13 0.12 (9.00) (20.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SLN Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 n/a (12.90) (25.50)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (9.00) (17.30)p n/a n/a n/a n/a 0.0%

Copyright © 2014 FactSet Research Systems Inc. All rights reserved.

SLN Company Announcements

Notice of Results 27-Aug-2014 15:38 RNS
Licensee confirms favourable trial outcome 30-Jul-2014 07:00 RNS
Second Price Monitoring Extn 18-Jul-2014 16:40 RNS

Latest SLN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Price Data

Currency UK Pounds
Share Price 208.00p
Change Today -6.88p
% Change -3.20 %
Volume 3,689
28-Aug-14 Close 214.88p
Shares Issued 52.00m
Market Cap 108.16m
Year End 31-Dec-13

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SLN Dividends

No dividends found

Trades for 29-Aug-2014

Time Volume / Share Price
11:02 1,783 @ 208.00p
11:02 567 @ 210.00p
11:02 1,250 @ 210.00p
09:07 89 @ 222.24p

SLN Key Personnel

Finance Director Tim Freeborn
CEO Ali Mortazavi
Chair Simon Sturge


www.bolsamania.com www.sharecast.com http://www.proshareclubs.co.uk/ www.digitallook.com